Welcome to Just an Ordinary Citizen

U.S. D.O.D issued contract for C-19 Research to a company in Ukraine, 3 months before C-19 was known to exist

 

The world first started to hear about a novel coronavirus in early January 2020, with reports of an alleged new pneumonia-like illness spreading across Wuhan, China. However, the world did not actually know of Covid-19 until February 2020, because it was not until the 11th of that month that the World Health Organisation officially named the novel coronavirus disease Covid-19.

So with this being the official truth, why does United States Government data show that the U.S. Department of Defence (DOD) awarded a contract on the 12th November 2019 to Labyrinth Global Health INC. for ‘COVID-19 Research’, at least one month before the alleged emergence of the novel coronavirus, and three months before it was officially dubbed Covid-19?

The shocking findings, however, do not end there. The contract awarded in November 2019 for ‘COVID-19 Research’ was not only instructed to take place in Ukraine, it was in fact part of a much larger contract for a ‘Biological threat reduction program in Ukraine’.

Perhaps explaining why Labyrinth Global Health has been collaborating with Peter Daszak’s EcoHealth Alliance, and Ernest Wolfe’s Metabiota since its formation in 2017.

The Government of the United States has a website called ‘USA Spending‘, an official open data source of federal spending information. According to the site as of 12th April 2021, the US Government has spent a mind-blowing $3.63 trillion “in response to COVID-19”. But that’s not the only information on Covid that can be found on the site.

 

Hidden within the ‘Award Search’ are details on a contract awarded by the Department of Defense to a company named ‘Black & Veatch Special Projects Corp‘, which is allegedly “a global engineering, procurement, consulting and construction company specialising in infrastructure development”.

The contract was awarded on September 20th, 2012 and is described as “Professional, Scientific, and Technical Services”. Obviously, this is very vague and most likely of little interest to anyone who happens to stumble across it. But there is something contained deep within the details that should be of interest to anyone and everyone.

The ‘Award History’ for the contract contains a tab for ‘Sub-Awards’ detailing the recipients, action date, amount, and a very brief description for 115 Sub-Award transactions. Most of the Sub-Awards are extremely mundane for things such as “laboratory equipment for Kyiv”, or “office furniture for Kyiv”.

But there is one Sub-Award that stands out among the rest, and it was awarded to Labyrinth Global Health INC for “SME Manuscript Documentation and COVID-19 Research”.

An award for Covid-19 research isn’t exactly shocking when the world is allegedly in the grip of a Covid-19 pandemic, but considering the fact the sub-contract was awarded 12th November 2019, at least one month before the alleged emergence of the novel coronavirus, and three months before it was officially dubbed Covid-19, the award for Covid-19 research should come as a shock to everyone.

But the shock doesn’t end there, because the place the contact for Covid-19 research was instructed to take place was Ukraine, as was the entire contract awarded by the DOD to Black & Veatch Special Projects Corp.

The contract details found on the ‘USA Spending’ site actually reveal that the specific DOD department that awarded the contract was the Defense Threat Reduction Agency (DTRA). The contract was awarded 20th September 2012, and concluded on 13th October 2020.

Why did both the DOD and said company then pay Labyrinth Global Health INC to carry out COVID-19 research in Ukraine at least one month before the alleged emergence of the novel coronavirus, and three months before it was officially dubbed Covid-19?

Founded in 2017, Labyrinth Global Health is allegedly a “women-owned small business with deep expertise and a proven track record supporting initiatives for scientific and medical advancement.”

They describe themselves as “a multicultural and international organization with offices in four countries and a team of experts with diverse backgrounds and competencies, including microbiology, virology, global health, emerging infectious disease nursing, medical anthropology, field epidemiology, clinical research, and health information systems.”

One of those offices just happens to be located in Kyiv, Ukraine, which the company dubs “a gateway to Eastern Europe”.

 

Here’s one of the many studies published by Eco Health Alliance, Metabiota and Labyrinth Global Health proving the connection –

Karen Saylors, PhD, who co-founded Labyrinth Global Health, has allegedly worked in the international public health field for over a decade and has spent many years living in Africa establishing global surveillance networks, “working with partners to improve Global Health policy on infectious disease detection, response, and control”.

But who are the partners that Dr Karen Saylors and Labyrinth Global Health choose to work with? They are none other than the ‘Eco-Health Alliance’ and ‘Metabiota’.

All of these people and organisations have been working for at least the last decade studying coronaviruses and helping to set up Biolabs in Ukraine. All using US Department of Defense funds to do so. You can read much more about this herehere and here.

A confidentiality agreement which can be viewed here, states that providers ‘Moderna’ alongside the ‘National Institute of Allergy and Infectious Diseases (NIAID) agreed to transfer ‘mRNA coronavirus vaccine candidates’ developed and jointly-owned by NIAID and Moderna to recipients ‘The University of North Carolina at Chapel Hill’ on the 12th December 2019.

The material transfer agreement was signed the December 12th 2019 by Ralph Baric, PhD, at the University of North Carolina at Chapel Hill, and then signed by Jacqueline Quay, Director of Licensing and Innovation Support at the University of North Carolina on December 16th 2019.

The agreement was also signed by two representatives of the NIAID, one of whom was Amy F. Petrik PhD, a technology transfer specialist who signed the agreement on December 12th 2019 at 8:05 am. The other signatory was Barney Graham MD PhD, an investigator for the NIAID, however, this signature was not dated.The final signatories on the agreement were Sunny Himansu, Moderna’s Investigator, and Shaun Ryan, Moderna’s Deputy General Councel. Both signautres were made on December 17th 2019.

All of these signatures were made prior to any knowledge of the alleged emergence of the novel coronavirus. It wasn’t until December 31st 2019 that the World Health Organisation (WHO) became aware of an alleged cluster of viral pneumonia cases in Wuhan, China. But even at this point, they had not determined that an alleged new coronavirus was to blame, instead stating the pneumonia was of “unknown cause”.

You now know that the VIRUS was planned and the evidence is now for you to see. 

Shocking Government Reports: Are the C-19 Vaccinated at Risk of Developing AIDS?”

 

UK PHE Vaccine Surveillance Report figures on Covid cases show that doubly vaccinated 40-70 year olds have lost 40% of their immune system capability compared to unvaccinated people. Their immune systems are deteriorating at around 5% per week (between 2.7% and 8.7%). If this continues then 30-50 year olds will have 100% immune system degradation, zero viral defence by Christmas and all doubly vaccinated people over 30 will have lost their immune systems by March next year.

The 5 PHE tables below from their excellent Vaccine Surveillance Report, separated by 4 weeks, clearly show the progressive damage that the vaccines are doing to the immune system’s response. 

People aged 40-69 have already lost 40% of their immune system capability and are losing it progressively at 3.3% to 6.4% per week.

Weekly Decline in doubly vaccinated immune system performance compared to unvaccinated people…

Everybody over 30 will have lost 100% of their entire immune capability (for viruses and certain cancers) within 6 months. 
30-50 year olds will have lost it by Christmas. These people will then effectively have full blown acquired immunodeficiency syndrome and destroy the NHS.
The vaccine booster shots have to be the same as the vaccines themselves, because it takes forever to do clinical trials and get approval for something different. So if you take a booster shot, these figures show that you are giving yourself an even faster progressive form of acquired immunodeficiency syndrome (after a couple of months of effectiveness).

Table 2. COVID-19 cases by vaccination status…

Cases reported by specimen date between week 32 and week 35 2021 – https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016465/Vaccine_surveillance_report_-_week_36.pdf 

Pfizer originally claimed a 95% efficiency for their vaccine 

But the figures above also show that the vaccines do NOT merely lose efficiency over time down to zero efficiency, they progressively damage the immune system until a negative efficiency is realised. They presently leave anybody over 30 in a worse position than they were before vaccination 

Children developed myocarditis and pericarditis

 

A study involving 1.7 million children in England aged between 5 and 15 years old has found that myocarditis and pericarditis only developed in children who had received Pfizer’s covid injections.  Not a single unvaccinated child in the group suffered from these heart conditions.

study was published in May 2024 by the Bennet Institute for Applied Data Science, a multidisciplinary team based at the University of Oxford. It was an observational study to assess the safety and effectiveness of the first and second doses of Pfizer-BioNTech’s (BNT162b2) covid injection in children and adolescents in England.  The injection was offered to this age group from September 2021 as part of the Government’s national covid injection campaign.

It compared data for at least 1,678,668 children and adolescents comprising:

  • 820,926 unvaccinated adolescents.
  • 441,858 adolescents who had received a first dose.
  • 283,422 unvaccinated children.
  • 132,462 children who had received a first dose
  • There is no indication of how many adolescents and children who had received a second dose were included in the study.

The study found that among 820,926 previously unvaccinated adolescents, the IRR for positive covid tests was 0.74 compared to vaccinated adolescents.  In other words, there was a lower incidence of covid (by positive test) in unvaccinated adolescents. 

The study included 283,422 unvaccinated children and 132,462 children who had received a first vaccine dose.  It found that covid-related outcomes used to measure effectiveness were too rare to estimate IRRs precisely in children. In other words, covid-related A&E attendance, covid-related hospitalisation, covid-related critical care admission and covid-related death for children (aged 5-11) were so rare that the authors were unable to assess the effectiveness of the covid “vaccine.”

As many researchers independent of corporate funds have been saying for years, why are children being vaccinated if they are not at risk from covid?  And it’s not only children who did not die with covid (i.e. after a positive test); no adolescents died with covid either.  As the study noted, “There were no covid-related deaths in any group [neither children nor adolescents].”

Worse still, the authors noted a problem with the safety of Pfizer’s injection for children – there were potentially serious health issues experienced by children after the first dose of Pfizer’s injection.  The study authors noted that A&E attendance and unplanned hospitalisation (the study’s measurements of safety) were slightly higher after the first vaccination (versus no vaccination) and slightly lower after the second vaccination (versus a single dose).

The most notable result of the study relates to myocarditis and pericarditis.  “Among both adolescents and children, myocarditis and pericarditis were documented only in the vaccinated groups, with rates of 27 and 10 cases/million after first and second doses respectively,” the study said.

You can read the OpenSAFELY study HERE

Click the banner below

Subscribe to the JAOC Newletter


*We respect all members right to privacy we do not share emails or personal data with any external companies or government office or dept.

JAOC Newsletter